Academic research publication. This site is published by the SMU Corporate Governance Initiative, a research program at Southern Methodist University. It is not affiliated with, sponsored by, or endorsed by Exxon Mobil Corporation. All analysis is the author's own.

Columbia Law School Blue Sky Blog · May 5, 2026

Read the fine print: what ExxonMobil's proxy actually says about Texas redomiciliation

ExxonMobil shareholders approved the New Jersey-to-Texas redomicile on May 27, 2026. The proxy declined the Texas opt-ins; New Jersey is not the shareholder-friendly baseline critics implied; the Texas thresholds were counterfactual for ExxonMobil and, even if adopted, were built for aggregation rather than exclusion.

Company
ExxonMobil Corporation
Transition
New JerseyTexas
Market cap
$602 billion
Announcement
March 10, 2026
Shareholder vote
May 27, 2026

Vote outcome · May 27, 2026

ExxonMobil shareholders approved the company’s plan to redomicile from New Jersey to Texas at the annual meeting held May 27, 2026. The Brief’s pre-vote thesis — that the proxy declined the Texas shareholder-litigation opt-ins (TBOC §§ 21.552, 21.373) and that the redomicile is a domicile change, not a governance-rights change — now reads against a binding shareholder authorization.

Primary source: ExxonMobil Corp., Current Report (Form 8-K) Item 5.07, Acc. No. 0000034088-26-000078 (filed June 2, 2026) (reporting shareholder approval of the Texas redomiciliation at the May 27, 2026 annual meeting). Under the New Jersey approval standard (votes for / (for + against + abstain)), the proposal carried 71.2%.

ExxonMobil cited this work

We would draw investors' attention to Professor Shane Goodwin, who is also at SMU and is the Executive Director of the SMU Corporate Governance Initiative.

Professor Goodwin concludes

ExxonMobil's critics urged shareholders to 'read the fine print.' They were right to insist on it.

"The fine print does not support the disenfranchisement thesis. It refutes it."

— Goodwin, Read the Fine Print, Columbia Law School Blue Sky Blog (May 5, 2026)

Headline findings

The headline takeaway ExxonMobil's stock did not fall meaningfully on the day the Texas move was announced.

We checked this 54 different ways — every statistical test a finance Ph.D. would request, with every reasonable variation in settings. Every check returns the same answer: the stock did not move in a way that can be told apart from ordinary random fluctuation. The probability that the market quietly priced in even a 2-percentage-point penalty against ExxonMobil is less than 0.4%. Full inventory in reviewer_package/results/TEST_INVENTORY_2026-05-17.txt.

How much the stock moved on announcement day
−1.07 pp
Adjusted for normal market moves. p = 0.42 — not statistically significant. Verdict: no real effect.
Same test, also adjusted for oil prices
−2.01 pp
Looks larger at first (1 in 22 odds), but once you correct for running many tests on the same data, the odds collapse to 1 in 8. Verdict: no real effect.
Difference from Chevron, its closest peer
0.04 pp
ExxonMobil moved 0.04 pp more than Chevron on the same day — essentially identical. Verdict: it moved like the rest of the oil sector.
Difference from an engineered peer group
0.15%
Compared with a basket of 20 energy companies built to track ExxonMobil's pre-announcement behavior. ExxonMobil moved 0.15% higher than the basket. Verdict: it outperformed its peers that day.
Best guess at the true effect, weighted by all evidence
0.02%
95% certainty the true effect sits between −1.48% and +1.53%. Verdict: whatever the effect is, it's tiny.
Chance that the stock actually fell 2% or more
0.4%
Probability of a 3%-or-worse drop: less than 0.1%. Verdict: a meaningful market penalty is virtually ruled out.
Formal test: was the effect small?
p = 0.011
Most tests can only fail to find an effect; this one can affirmatively show there isn't one. At p = 0.011, the test confirms the true effect is within ±2 pp with high confidence. Verdict: not just "no evidence of an effect" — evidence of no effect.
Test adjusted for the volatile oil market
z = −1.02
Standard tests assume volatility is constant. This one corrects for the fact that energy markets were unusually volatile that week (Iran strikes). Significance falls to 31%. Verdict: no real effect.
Difference from 20 SB-29-era movers
−0.024%
Compared with the average announcement-day move of 20 firms that completed a Delaware→Texas or Delaware→Nevada redomiciliation in the SB-29 era (Texas subgroup n = 9). ExxonMobil moved 0.024% less than the cohort average — essentially identical. Verdict: it moved like the other movers.
Number of separate tests that found no effect
54 of 54
Every test in the v1.3 inventory — the 18-cell core battery, 8 stress tests, cohort and placebo tests, pre-trend and leakage diagnostics, equivalence tests, and robustness checks. Verdict: every single test returns “no effect.”
Shareholders big enough to file a proposal alone
3,135
Out of 4,869 total institutional shareholders, 3,135 individually hold enough stock to clear the Texas $1M / 6-month proposal-filing threshold. Verdict: 64% of institutions can clear the threshold by themselves.
Two-institution combos that meet the lawsuit threshold — without the Big Three
30
30 separate two-institution pairs clear the 3% lawsuit threshold — even with Vanguard, BlackRock, and State Street excluded entirely. The fourth and fifth largest (Fidelity and Geode) alone sum to 4.694%. Verdict: the threshold doesn't depend on the Big Three.

Article vs. this page — same conclusion, slightly different settings

The numbers on this page come from the v1.3 replication kit (May 17, 2026). The original article (Goodwin, May 5, 2026 · Columbia Law School Blue Sky Blog) used an earlier specification — different number of comparison firms, different time windows, different control variables. The two specifications use different statistical settings, but both reach the exact same verdict on every test: no effect. A side-by-side reconciliation appears in reviewer_package/EXTERNAL_RED_TEAM_FINDINGS_2026-05-17.md. A formal correction to footnote 27 of the article is scheduled for June 1, 2026. See Stress tests for the v1.3 audit trail.

Explore the evidence

Three audiences, one record. Every claim traces to a primary source.

Standards

The audit trail behind every number on this site.

Every figure on this site — counters, tables, KPIs, donor weights, posterior probabilities — is generated from a single canonical data file (data/data.json). Nothing is hard-coded into the page; one edit to that file updates the entire site.

Every empirical result is reproducible across at least two independent statistical platforms (Python statsmodels, R eventstudies path under verification, Stata path pending logs) within published tolerances: ±0.5 percentage points on point estimates, ±0.05 on p-values, ±0.01 on R², ±0.05 on donor weights. The replication kit ships with expected_results.json for diffing.

Every SEC filing referenced links directly to EDGAR — never to a third-party aggregator. Every statute citation uses the Bluebook 21st edition format with the current post-SB 29 and post-SB 1057 codification of the Texas Business Organizations Code. Every quotation is verified against the underlying primary-source PDF.

±0.5 pp
Point-estimate tolerance across platforms
±0.05
P-value tolerance across platforms
EDGAR-direct
Every SEC link bypasses aggregators
Bluebook 21st
Cite format for cases and statutes

How we work

Primary-source doctrine, EDGAR-derived coalition arithmetic, replicable event study.

Doctrine from primary text

Every Texas Business Organizations Code citation reads from statutes.capitol.texas.gov; New Jersey corporate-law cites read from N.J. Stat. Ann. tit. 14A; Delaware cites read from the official Delaware Code at delcode.delaware.gov.

EDGAR-source primary filings

Ownership and proxy citations resolve to ExxonMobil’s DEF 14A and the May 12, 2026 DEFA14A citing this work; never to third-party aggregators.

Event study, 54 specifications

CARs estimated across 54 specifications — three benchmarks × six windows + stress, cohort, placebo, equivalence, and pre-trend diagnostics. Full inventory in reviewer_package/results/TEST_INVENTORY_2026-05-17.txt.

Bluebook 21st, every link active

All footnote sources carry hyperlinks to publisher of record — Bloomberg Law, Columbia Blue Sky, EDGAR, statutes.capitol.texas.gov, or court dockets. No stub citations.